Moderna announces changes to commercial organization to prepare for multiple product launches in 2024 and 2025

Cambridge, ma / accesswire / december 12, 2023 / moderna, inc. (nasdaq:mrna) today announced changes to its operating model to bring focus to its short- and long-term business goals. the company is focused on driving continued sales of its covid-19 vaccine and launching its rsv vaccine in 2024, while also preparing to launch multiple products per year from 2025 forward.
MRNA Ratings Summary
MRNA Quant Ranking